Report: Johnson & Johnson sees Vision Care biz grow, looks to expand beyond contacts

April 23, 2018 By Fink Densford Leave a Comment

Johnson & Johnson (NYSE:JNJ) saw its vision care sales grow 34% last quarter over its previous first quarter as it looks to significantly grow the business into the surgical and device segments, according to a CNBC report.

The company added a number of surgical products alongside a contact subscription service, which come in addition to its existing popular Acuvue contact lens line, according to the report. The investment has seen a significant return for the company, becoming one of its fastest-growing platforms.

Johnson & Johnson only began investing in eye surgery two years ago after announcing it would acquire Abbot Medical Optics for $4.3 billion. The acquisition put products covering cataract surgery, laser refractive surgery and consumer eye health into its portfolio, which the company folded into the medical device segment within J&J Vision Care.

The company also picked up TearScience and Sightbox, which make devices to treat dry eyes and operate a subscription-based contact lens biz, respectively.

“I would say it really starts with the space of sight, and sight matters, we like to say. It’s one of the largest and fastest growing segments in health care, and we think there’s still a lot of unmet need. What (the vision team is) doing is really evolving the business model to better serve more patients, quite frankly, and create a much better customer experience behind some really modern and differentiated technology and ways to service patients,” J&J consumer medical devices group chair Ashley McEvoy said, according to CNBC.

Johnson & Johnson is bullish on the market for eyecare products, with J&J Vision surgical prez Tom Frinzi estimating the market to be worth $80 billion, with an estimated 253 million individuals living with vision impairment, according to the report.

The addition of cataract and surgical products expands the company’s portfolio to meet a growing, and aging market, according to the report.

“If you just think of the broad-based portfolio, we have everything from prevention to correction and enhancement, all the way through to treatment, and there are not many companies that can bring that to bear on behalf of patients around the world,” Frinzi said, according to CNBC.

The company still has room to grow, however, as it has no offerings in the retina or glaucoma space, according to the report.

Last week, Johnson & Johnson reported first-quarter sales and earnings that topped the consensus forecast on Wall Street, despite lower profit numbers, and said it plans to make changes to its supply chain that could save as much as $800 million annually.

Accu-Tube launches rebrand for 45 year anniversary
Accu-Tube announced that it has updated its branding with a new logo, colors and website during the company’s 45 year anniversary celebration. The new branding comes with improvements to the company that will go toward helping Accu-Tube grow and expand. “We are very proud of our reconfiguration across all spaces,” Kevin McGrath, CEO of Accu-Tube,… […]
Spectrum Plastics adds overmolding at Utah plant
Spectrum Plastics Group said today that it has begun to offer value-added overmolding at its Apollo Medical operation in Sandy, Utah. The Alpharetta, Ga.-based company added four new injection molding machines ranging from 11 to 55 tons, at Apollo. The machines are suitable for injection molding of highly precise products, including dilator and sheath sets, allowing Spectrum to… […]
11 innovative medical devices you need to know from 2018
Call it digital health or mHealth or simply what it is — innovation. Last year we saw a lot of innovative wireless devices for diagnostics and treatment as research and development flourished. Many researchers have taken up the challenge of developing devices that are portable, small and convenient with ease-of-use that could revolutionize point-of-care diagnostics… […]
Study of VentureMed’s Flex catheter begins in Switzerland
Vascular-focused device developer VentureMed said yesterday that it has launched another study of its Flex dynamic scoring catheter, this one to measure how open patients’ blood vessels remain 12 months after treatment. The prospective, single arm, non-randomized study in Switzerland will enroll up to 150 patients whose superficial femoral and popliteal arteries were scored by the Flex system… […]
Grand Valley State lands grant to study 3D printing for medtech
Grand Valley State University’s applied Medical Device Institute (aMDI) has been awarded $500,000 by the Grand Rapids SmartZone to study the use of specialized 3D printing technology for medical device production. The grant will allow the Grand Rapids, Michigan-based institute, along with contract manufacturer MediSurge (Grand Rapids) and 3D printing company Carbon (Redwood City, Calif.) to create production-grade,… […]
Abbott inks deal to test blood donations in Japan
Abbott (NYSE:ABT) said today that it has been selected by the Japanese Red Cross Society (JRC) to partner in screening the country’s blood donations. The eight-year contract is for the exclusive supply of serological instrumentation, tests, and consumables used for blood and plasma screening. The JRC screens approximately 5 million blood donations each year, helping ensure… […]
LivaNova touts studies of its sutureless aortic valve
LivaNova (NSDQ:LIVN) said today that three separate, recently published studies highlight the performance and cost savings of its sutureless aortic valve, Perceval. The results from the Perceval Aortic Heart Valve Study in North America found that Perceval achieves positive safety and efficacy outcomes whether or not an open or minimally invasive surgical approach is used. The… […]
OtoNexus raises $4.4 million for ear infection detection technology
OtoNexus (Seattle) has raised more than $4.4 million as it continues to develop its ultrasound medical device technology to diagnose middle ear infections, according to a U.S. Securities and Exchange Commission Form D filed this month. OtoNexus has been seeking a nearly $8.3 million from the money-raise. It previously raised $7.8 million in 2017. Funders and supporters… […]
Bioventus launches Osteomatrix+ bone graft
Bioventus announced today that it has started selling Osteomatrix+ – a moldable bone graft substitute intended for a variety of orthopedic and spine bone remodeling applications. Bioventus officials boast that Osteomatrix+ has improved moldability, flexibility and versatility versus its predecessor. “Osteomatrix+ represents the first of several next-generation products that will be added to the Bioventus portfolio… […]
European scientists develop absorbable bandages for burn patients
An international research group has developed a biocompatible bandage material that has antibacterial properties and will not require changing, a potential boon for burn patients. The material is self-absorbable, and a new bandage can be put directly on top of the old one, alleviating the need for the frequent and often-painful changing of a burn… […]
17 MD&M West exhibitors you need to know
More than 20,000 engineers and executives are expected to gather and network for the annual MD&M West – one of the largest annual medical device manufacturing events. MD&M West takes place at the Anaheim Convention Center in Anaheim, Calif., Feb. 5–7, and houses an array of industry suppliers showcasing their latest technologies and manufacturing advancements. Think medical device packaging,… […]